(EMAILWIRE.COM, April 06, 2022 ) The Mammalian Cell Banking Market is destined to grow on an impertinent note, i.e. reaching US$ 1.1 Bn at a CAGR of 14% between 2020-2030. Personalization has taken over almost every sphere of the industry verticals, and healthcare is no exception. People have started looking at their healthcare picture such that they could actively take part in improving their physical and mental health on the daily basis. This personalization will be the face of the healthcare vertical in the forecast period.
Cell banks allow the storage and generation of detailed characterizations of cell lines with specific genomes for research use. Mammalian cells are mostly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.
Get a Free Sample Copy Of the Mammalian Cell Banking Market Report@ https://www.persistencemarketresearch.com/samples/31663
The mammalian cell banking market is expanding with increasing cancer research. Companies are channelizing efforts to maximize productivity, flexibility, and throughput capabilities. Additionally, with the research communitys ever-evolving needs, the demand for specialized cell culture has grown, and due to this, most manufacturers that are currently offering these services cannot depend solely on sales from catalog services.
According to the latest report published by PMR, the global mammalian cell banking market is projected to account for US$ 1.1 Bn, in terms of value, by 2030 end. The report further projects that the mammalian cell banking market will progress at an average CAGR of 14% through 2030.
Sartorius Stedim BioOutsource Limited.
Charles River Laboratories.
Eurofins DiscoverX Corporation
Lonza Group Ltd
Switch Over To The Methodology Tab@ https://www.persistencemarketresearch.com/methodology/31663
Key Takeaways of Mammalian Cell Banking Market Study
The CHO segment, under cell, is expected to contribute more than 60% of revenue share in the mammalian cell banking market.
Various services launched by key players along with customized service offerings are expected to dominate the demand for working cell banks.
Leading players in the mammalian cell banking market are collaborating with research institutes as well as a contract research organizations to strengthen their market position.
North America holds more than half of the global mammalian cell banking market share. With the increasing use of technology, rapid industrialization, and more research programs, growing economies such as East Asia will experience increased growth in the mammalian cell banking market.
Rising demand for cell lines for producing vaccines to combat the COVID-19 outbreak is boding well for the growth of the mammalian cell banking market.
The global mammalian cell banking market is expected to witness robust growth during the forecast period. Increase demand for cell banking and its application in cancer research are expected to propel market growth over the next decade, says a PMR analyst.
Acquisitions & Partnerships Key Strategies amongst Market Players
Key players in the mammalian cell banking market are improving their product portfolios and strengthening their market positions though the launch of new products and services.
For instance, in August 2019, Sartorius Stedim BioOutsource Limited launched a new services for mammalian cell bank manufactures under GMP conditions.
In January 2019, Charles River Laboratories announced the expansion of cell banking services at its Malvern, PA, site.
Various players in the mammalian cell banking market are focusing on growth strategies such as acquisitions and partnerships.
For example, in June 2019, Selexis SA announced a partnership with Avacta Group Plc for cell line development.
Purchase Now@ https://www.persistencemarketresearch.com/checkout/31663
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the mammalian cell banking market in its latest study, presenting historical demand assessment of 20152019 and projections for 20202020, on the basis of cell (CHO, BHK, NS0, YB2/0 & P2/0, HEK293 & derivatives, and HELA), technology (transient expression platforms, inducible expression platforms, and stable expression platforms), cell bank (master cell banks (MCBs), working cell bank (WCBs), End of Production Cell Banks (EoPCBs), and research & development cell banks (R&D CBs)), and end user (contract research organizations (CROs), research & academic institutions, and biopharmaceutical companies), across seven key regions.
Access Related Reports-
The global liposomes market was valued at US$ 6.5 Bn in 2019 and is expected to expand at a CAGR of around 7% during the forecast period (20202030).
Bone Marrow Transplantation Market-
The global bone Marrow Transplant Market is expected to exceed US$ 12 Bn by the end of 2028. The bone marrow transplantation market is expected to grow at a CAGR of 3.6% through the forecast period 2018-2028.
The global microRNA market is estimated to represent US$ 100.4 Mn of the total market in 2017 and is estimated to reach US$ 187.8 Mn by 2025 end, expanding at a CAGR of 8.1% over the forecast period of 20172025.
Europe Cryochambers Market-
In this report, PMR has focused on offering detailed insights & in-depth research on the global cryochambers market over an eight-year forecast period from 2016 to 2024.
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353